本文選題：腦梗死 + 出血轉化�。� 參考：《臨床醫(yī)學工程》2016年12期

【摘要】：目的探討腦梗死出血轉化后繼續(xù)服用阿司匹林臨床抗血小板聚集的效果。方法選取我院2013年1月至2015年12月期間120例急性腦梗死入院治療出現出血癥狀的患者,按雙盲法隨機分為實驗組60例、對照組60例。在給予相應對癥治療的同時,實驗組繼續(xù)使用阿司匹林,對照組停止服用抗血小板聚集藥物并在出血穩(wěn)定后繼續(xù)啟用。結果治療后,實驗組較對照組纖維蛋白水平指標恢復好(P0.05),經頭顱CT檢查顯示兩組的腦出血量均未見明顯增加(P0.05)。治療前和治療3個月后,兩組神經損傷程度比較無統(tǒng)計學差異(P0.05);治療1個月后,實驗組的神經損傷程度評分顯著低于對照組(P0.05)。結論對腦梗死出血轉化患者,臨床發(fā)現出血后繼續(xù)使用阿司匹林抗血小板治療,有利于神經功能恢復和血液流變學指標恢復。
[Abstract]:Objective to investigate the effect of aspirin on platelet aggregation after cerebral infarction. Methods from January 2013 to December 2015, 120 patients with acute cerebral infarction were randomly divided into experimental group (n = 60) and control group (n = 60). While the corresponding symptomatic treatment was given, the experimental group continued to use aspirin, while the control group stopped taking the antiplatelet aggregation drug and continued to use it after the bleeding stabilized. Results after treatment, the fibrin level of the experimental group recovered better than that of the control group (P0.05A), and the cerebral hemorrhage volume of the two groups was not significantly increased by CT examination. There was no significant difference in the degree of nerve injury between the two groups before and after 3 months of treatment, but after one month of treatment, the score of nerve injury in the experimental group was significantly lower than that in the control group (P 0.05). Conclusion Aspirin antiplatelet therapy is beneficial to the recovery of nerve function and hemorheology in patients with cerebral infarction.
【作者單位】： 廣東省高州市人民醫(yī)院;
【分類號】：R743.33
，

本文編號：1955116